Dr. Lal Path Labs Ltd (LALPATHLAB)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 3170.00
% Change: -1.52% (Prev Close: 3219.00)

Volume: 41,011
% Change: -40.13% (Prev Volume: 68,499)

Delivery: 23,601
Delivery % : 57.55
% Change: -39.83% (Prev Delivery: 39,225)

Turnover: 1,307 Lacs
% Change: -40.41% (Prev Turnover: 2,193)

πŸ’Ή EOD Valuation

P/E Ratio: 51.67
P/B Ratio: 12.20
Market Cap: 26565 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: LALPATHLAB
Market Cap: 27720 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 3653.95
52 Week Low: 2293.55

All-Time High: 4245.50 Rs.
All-Time Low: 696.50 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
4.48% | 17.27% | 33.87% | -1.93% | 12.10%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 53.79%

Change (3Y | 1Y): -1.26% | -0.12%

Pledged %: 0.00%

FII Holding

FII Holding: 21.69%

Change (3Y | 1Y): -0.68% | -2.21%

DII Holding

DII Holding: 17.62%

Change (3Y | 1Y): 11.10% | 1.83%

Public Holding: 6.22%

🏦 Financial Strength

Debt to Equity: 0.07
Debt: 157.43 Rs. Cr.

Book Value: 259.92 Rs.
Current Ratio: 2.58
Interest Coverage: 32.23
Free Cash Flow: 515.69 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 10.57%

Sales Growth Qtr (YOY | QoQ):
11.28% | 11.15%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
13.09% | 5.65% | 10.57%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 34.50%

Profit Growth Qtr (YOY | QoQ):
24.44% | -13.83%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
16.69% | 12.28% | 34.50%

EPS Rs.

EPS (TTM): 61.35 Rs.

EPS Qtr (Last Year | Latest):
12.75 Rs. | 15.80 Rs.

EPS Annual (Last Annual | Annual March):
42.85 Rs. | 58.28 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
16.63% | 12.17%

Net Profit Rs. Cr.

Net Profit (TTM): 518.40 Rs. Cr.

Net Profit (Annual - March): 492.25 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
107.80| 155.50 | 134.00

EBITDA Rs. Cr.

EBITDA (Quarter): 220.40 Rs. Cr.
EBITDA (Previous Yr Ql): 190.60 Rs. Cr.

EBITDA (Annual - March): 791.18 Rs. Cr.
EBITDA (Previous Annual): 678.63 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
14.70% | 8.83%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 28.38%

OPM Qtr (Previous | Current):
28.05% | 28.71%

OPM Annual (5 Yrs | Last Yr | March):
26.94% | 27.37% | 28.35%

Return on Equity %

ROE: 24.30%

ROE (5 Yrs | 3 Yrs | Last Yr):
21.89% | 20.27% | 20.36%

Return on Capital Employed %

ROCE: 28.88%

ROCE (5 Yrs | 3 Yrs | Last Yr):
26.85% | 24.07% | 25.17%

Return on Assets %

ROA (TTM): 19.11%

ROA (5 Yrs | 3 Yrs | Last Yr):
16.27% | 14.76% | 14.99%

PEG Ratio: 4.40
Dividend Yield: 0.73%

PE 3 Yrs: 67.19
PE 5 Yrs: 71.19

Dividend Yield: 0.73%

πŸ‘₯ Company

Dr. Lal Path Labs Ltd

LALPATHLAB

Promoter Holding: %